Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Neoplasms 2Esophageal Squamous Cell Carcinoma 2Biliary Tract Neoplasms 2Advanced Gastric Cancer 2Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Stomach Neoplasms 1Respiratory Tract Diseases 1Recurrence 1Rectal Neoplasms 1Pyloric Stenosis, Hypertrophic 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Lung Diseases 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced or Metastatic Gastric Adenocarcinoma 1Hepatic Metastasis of Colorectal Cancer 1Esophageal Neoplasms 1Disease Progression 1Colorectal Neoplasms 1Colorectal Cancer Recurrent 1Carcinoma, Non-Small-Cell Lung 1CRC 1

Interventions

selpercatinib 2repotrectinib 1pralsetinib 1pembrolizumab 1osimertinib 1ficlatuzumab 1efineptakin alfa 1cobimetinib 1camrelizumab 1atezolizumab 1apatinib 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Thoracic Neoplasms × camrelizumab × Clear all
NCT04133337 2019-10-21

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Sichuan Cancer Hospital and Research Institute

Phase 1/2 Unknown
20 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡